|
|
||||||||
1 The Copenhagen Muscle Research Centre, 2 The Department of Infectious Diseases, Rigshospitalet, 3 The Technical University of Denmark, and 4 The August Krogh Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark
| |
ABSTRACT |
|---|
|
|
|---|
The aim of the present study was to
investigate whether fish oil supplementation was able to modulate the
acute-phase response to strenuous exercise. Twenty male runners were
randomized to receive supplementation (n = 10) with 6.0 g fish oil daily, containing 3.6 g n-3 polyunsaturated fatty acids
(PUFA), for 6 wk or to receive no supplementation (n = 10) before participating in The Copenhagen Marathon 1998. Blood samples
were collected before the race, immediately after, and 1.5 and 3 h
postexercise. The fatty acid composition in blood mononuclear cells
(BMNC) differed between the fish oil-supplemented and the control
group, showing incorporation of n-3 PUFA and less arachidonic acid in
BMNC in the supplemented group. The plasma levels of tumor necrosis
factor-
, interleukin-6, and transforming growth
factor-
1 peaked immediately after the run, the increase being 3-, 92-, and 1.1-fold, respectively, compared with resting samples. The level of interlukin-1 receptor antagonist peaked 1.5 h after exercise, with the increase being 87-fold. However, the
cytokine levels did not differ among the two groups. Furthermore, supplementation with fish oil did not influence exercise-induced increases in leucocytes and creatine kinase. In conclusion, 6 wk of
fish oil supplementation had no influence on the acute-phase response
to strenuous exercise.
interleukin; sport; muscle
| |
INTRODUCTION |
|---|
|
|
|---|
STRENUOUS EXERCISE
INDUCES an acute-phase response that has similarities to that
observed in sepsis and trauma (31), including increased
plasma concentrations of interleukin (IL)-6 (26), IL-1
receptor antagonist (IL-1ra) (30), and tumour necrosis factor-
(TNF-
) (13, 29). Sepsis and trauma are
associated with increased plasma levels of transforming growth factor
(TGF)-
1 (18, 21-23, 38).
TGF-
1 is an anti-inflammatory cytokine that represses
the production of inflammatory cytokines by activated macrophages
(4) and induces the release of soluble TNF receptors and
IL-1ra (39). The effect of exercise on this cytokine has not been investigated.
The n-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid and docosahexaenoic acid, both found in fish oils, suppress the production of arachidonic acid, derived 2-series prostaglandins, and the 4-series leucotrienes (16) that modulate the production of proinflammatory and immunoregulatory cytokines (7). In addition, eicosapentaenoic acid is a substrate for the synthesis of an alternative family of eicosanoids, the 3-series prostaglandins and the 5-series leucotrienes (5).
Dietary fats that are rich in n-3 PUFA have the potential to alter
cytokine production. Animal studies indicate that n-3 PUFA-rich oils
reduce the response to endotoxin and to proinflammatory cytokines (7). Thus these studies provide evidence that feeding
plant or fish oils that are rich in n-3 PUFA alters the ex vivo
production of TNF-
, IL-1, IL-2, and IL-6 (3, 19, 20,
37); however, contradictory observations do exist. Human studies
provide more consistent data. Several studies have shown that
supplementation of the diet of healthy volunteers with fish oils
results in reduced production of IL-1, IL-6, TNF-
, and IL-2 by
peripheral blood mononuclear cells (BMNC) in vitro (12).
There are no human studies examining in vivo cytokine production after
supplementation with n-3 PUFA.
Other studies examined the influence of n-3 PUFA in exercising humans, finding no difference in endurance performance (27, 32), no major changes in acute phase reaction proteins (15), and unchanged red blood cell deformability (27). Aguilaniu et al. (1, 2) investigated the exercise-related hypoxemia that was reduced in n-6 PUFA supplemented athletes (1, 2).
Changes in in vitro cell function induced by n-3 PUFA supplementation to humans have been intensively studied, finding reduced 4-series leucotrienes production by neutrophils, reduced neutrophil (14) and monocyte (35) chemotaxis to several agents, and inhibited neutrophil superoxide production (9, 41), although the last point is controversial (17).
In this experiment, exercise is used as a model of inflammation to study the effects of dietary supplementation with n-3 PUFA on in vivo cytokine production during strenuous exercise.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Subjects. Twenty healthy, endurance-trained, volunteer athletes (men) completed the Copenhagen Marathon Race on May 18, 1998. None of the subjects was taking any medication. The experimental protocol was approved by the local ethics committee of the Copenhagen and Frederiksberg Communities. All subjects were informed about the purpose and risks of the study before their written, informed consent was obtained. Ambient temperature during running was 19°C.
For each subject, maximal oxygen consumption (
O2 max) was determined before the
experiment during an incremental exercise test on treadmill.
Study design. Twenty men who were endurance-trained runners were randomized to receive supplementation (n = 10) of fish oil in capsules (Pikasol, Lube) 6.0 g daily, containing 3.6 g of n-3 PUFA (53% eicosapentaenoic acid and 31% docosahexaenoic acid) and 21.6 mg tocopherol for 6 wk or to receive no supplementation (control group; n = 10) before participating in The Copenhagen Marathon 1998.
The subjects were instructed to consume carbohydrate-rich foods (>8 g carbohydrate per kg of body mass per day) and fluids for 6 wk before the experiment, as well as 2 days after. The subjects prepared for the preexercise sample in a way similar to their preparations for the marathon race. This preparation involved refraining from exercise for 2 days before the preexercise sample was obtained.Sampling of blood and preparation of plasma, serum, and cells. Blood samples were drawn from the antecubital vein one week before the race, immediately after (median: 10 min, range: 2-23 min), and 1.5 and 3.0 h postexercise. The preexercise sample was taken 1 wk before the race to avoid influencing the performance of the runners. The subjects were kept at rest for 3 h postexercise, during which postexercise samples were taken.
For cytokine measurements, two 10-ml blood samples were drawn into glass tubes containing 35 µmol dipotassium-EDTA and 1,500 kallikrein inactivator units Trasylol (Bayer, Leverkusen, Germany). The tubes were kept on ice until they were centrifuged at 2,500 g for 15 min at 4°C. Serum was isolated from blood samples drawn into endotoxin-free tubes without EDTA. Plasma and serum were stored at
80
and
20°C respectively.
For BMNC membrane phospholipid analysis after the supplementation
period, a 20-ml blood sample was drawn into a glass tube containing
heparin (nonconserved; 100 µml, 5,000 IE/ml; SAD). BMNC were isolated
by density-gradient centrifugation (Lymphoprep, Nycomed Pharma, Oslo,
Norway) on LeucoSep tubes (Greiner, Frickenhausen, Germany) and washed
three times with stock solution I and Hanks' (Bie and Berntsen AS,
Rødovre, Denmark) solution. BMNC were frozen in freezing medium and
kept in liquid nitrogen until thawed for analysis.
Measurement of cytokines.
TNF-
, IL-6, and IL-1ra were measured in plasma. TGF-
1
was measured in serum. Cytokines were analyzed by commercially
available enzyme-linked immunosorbent assay (ELISA; R & D Systems,
Minneapolis, MN). All measurements were performed in duplicate, and
high-sensitivity kits were used when available (which was the case for
IL-6 and TNF-
but not for IL-1ra and TGF-
1).
According to information provided by R & D Systems, the ELISA used for
measuring IL-6 and TNF-
are insensitive to the addition of the
recombinant forms of the soluble receptors (sIL-6r, sTNF-r1, and
sTNF-r2, respectively), and these measurements, therefore, correspond
to both soluble and receptor-bound cytokine. For the cytokine ELISA,
the detection limits were IL-6 < 0.094, TNF-
< 0.18, IL-1ra < 22, and TGF-
1 < 7, all in pg/ml.
The intra-assay coefficients of variation were IL-6 = 6.0%,
TNF-
= 4.9%, IL-1ra = 6.2% and TGF-
1 = 5.3%.
Correction for plasma volume shifts. Changes in plasma volume caused by dehydration were calculated from measurements of hemoglobin and hematocrit, according to the method described by Dill and Costill (10). Cytokine, creatine kinase (CK), and leucocyte measurements were corrected accordingly, with a median correction factor of 0.96 (range: 0.72 to 1.1) immediately after the race.
Clinical chemistry analysis. All clinical chemistry analyses were performed by the Central Laboratory at the University Hospital of Copenhagen. Measurements of hemoglobin, hematocrit, lymphocytes, and neutrophils were done by a cell counter (SE-9000, Toa-Sysmex, Hamburg, Germany). CK was measured using automated enzyme reactions (Hitachi Systems 717, Boehringer Mannheim Diagnostica).
BMNC lipid analysis. The thawed cell pellets were washed three times with isotonic saline, suspended in 1 ml methanol with 0.002% 2,6-di-tert-butyl-p-cresol, and sonicated for 45 s. Lipids were then extracted quantitatively with 3 ml of 0.002% BHT in methanol-chloroform (2:1 ratio), followed by 2 ml of methanol-chloroform (1:1 ratio). The pooled supernatants were evaporated to dryness, dissolved in 540 µl of ether-methylacetate-sodium methoxide in methanol (25:1:1 M ratio), and vortexed for 10 s. After a 5-min reaction time, the mixtures were neutralized with acetic acid, evaporated to dryness, and the methyl esters were extracted by addition of 1 ml heptane and 200 µl H2O.
Separation of fatty acid methyl esters was performed on a HP6890 chromatograph (Hewlett-Packard, Wilmington, DE) fitted to a 50-m fused silica capillary column (CPSil88, 0.25 mm ID, film thickness = 0.20 µm; Chrompack, Middelburg, The Netherlands), with a temperature rise from 150 to 220°C at 4°C/min. The injection temperature was 250°C, and the detector temperature was 270°C. Helium was used as the carrier gas, at 33 psi, with a 1- to-10 split ratio. PUFA were identified by comparison with authentic standards (Nu Chek Prep, Elysian, MN), and the results are expressed as percentage by weight.Statistical analysis.
The measurements of cytokines, leucocytes, and CK were tested for
effects of time and group in a repeated-measures ANOVA. The model used
was
|
| |
RESULTS |
|---|
|
|
|---|
The two groups did not differ regarding age, height,
weight,
O2 max, and racing time (Table
1).
|
Effect of exercise.
Strenuous exercise induced increases in the plasma concentration of
TNF-
(3-fold), IL-6 (92-fold), IL-1ra (87-fold), and TGF-
1 (1.1-fold) (P < 10
10 for TNF-
, IL-6, and IL-1ra; P < 10
4 for TGF-
1; Fig.
1). Maximal levels of TNF-
, IL-6, and
TGF-
1 were found immediately after the race, whereas
IL-1ra peaked 1.5 h afterward. Cytokine levels declined during the
resting period and remained significantly different from the prerace
values until at least 3 h after running (Fig. 1). Peak IL-6 was
not correlated to peak CK (r = 0.3; P = 0.2; n = 19).
|
5; Fig.
2A). The neutrophil
concentration was increased fivefold immediately after the exercise
compared with prerace values and remained unchanged at 1.5 h
postexercise (P < 10
10; Fig.
2B). CK peaked the day after the race with a 17-fold
increase and declined the following day (P < 10
10; Fig. 2C).
|
Effect of supplementation. Comparing the n-3 PUFA-supplemented group with the control group, there were no differences in cytokine levels, neutrophil and lymphocyte concentrations, or CK levels (see Figs. 1 and 2).
Statistically significant differences between the fish oil-supplemented and control groups were observed for the fatty acids (20:4 n-6 arachidonic acid, 20:5 n-3 eicosapentaenoic acid, and 22:5 n-3) and, consequently, for the sums
n-6 PUFA,
n-3 PUFA, and the
n-6
PUFA-to-
n-3 PUFA ratio (P < 0.01), with all showing incorporation of n-3 PUFA and less arachidonic acid in BMNC than the
supplemented group. No differences were observed among the other fatty
acids (Table 2).
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study showed that strenuous exercise induces
significant increases in TNF-
, IL-6, and IL-1ra, and these findings support previous observations (8, 11, 26, 28-30, 33, 36, 40). Plasma levels of TGF-
1 have been shown to
increase in response to sepsis (18, 23) and trauma
(21, 22, 24). Exercise induced a small but significant
increase in the plasma concentration of this cytokine. We are not aware
of any other studies investigating the influence of exercise on
TGF-
1. Sepsis, trauma, and exercise seem to induce
similar effects on TGF-
1, even though the
exercise-induced increase was only 10% compared with the twofold
increase observed in response to sepsis (23). In contrast,
when comparing the TNF-
and IL-6 responses to those of severe
pneumococcal infections (6) and of a marathon (29, 30), almost identical cytokine levels were found.
A previous study, which used an eccentric exercise model (5), showed that IL-6 was associated with muscle damage. However, in the present running model, we were unable to find any association with muscle damage, as visualized by increased levels of CK and peak IL-6.
The present study indicates that exercise induces production or release of cytokines by mechanisms other than that seen in sepsis. Thus, in other experimental models in which n-3 PUFA supplementation had an effect, cytokine production was stimulated by endotoxins (lipopolysaccharide). It has not been previously shown that exercise induces an increase in cytokine production through endotoxins. The latter mechanism is likely to play a role only in extreme exercise situations and to only be partly responsible for the exercise-associated increase in cytokines (25).
A main purpose of this study was to evaluate whether n-3 PUFA
supplementation affected the acute-phase response to exercise. However,
the present study clearly showed that n-3 PUFA supplementation for 6 wk
did not induce any effects on plasma levels of TNF-
, IL-6, IL-1ra,
or TGF-
1. Furthermore, we found no effects on neutrophil and lymphocyte concentrations and no influence on muscle damage, as
visualized by the plasma CK level.
An alternative explanation for the contrasting findings regarding n-3 PUFA influences on cytokine levels between a previous animal study (7) and the present human study is that much higher doses of fish oil and longer supplementation periods were used in the animal experiment. In this study, doses of n-3 PUFA were sixfold higher than the daily dietary dose recommended by The European Union's Scientific Committee for Food (34). Furthermore, PUFA analyses showed that we were able to identify two groups that differed with respect to the amount of n-3 PUFA in BMNC plasma membranes. Thus significant differences were observed for the fatty acids (20:4 n-6 arachidonic acid and 20:5 n-3 eicosapentaenoic acid) in the fish oil-supplemented group compared with controls. These fatty acids are precusors to different series of eicosanoids. This finding strongly indicates that the supplemention period and the amount of fish oil were sufficient for our purposes, and that fish oil supplementation is not likely to have any effect on exercise-induced cytokine production, even if given in larger doses or for longer time period.
In conclusion, the present study found that strenuous exercise enhances
the plasma levels of TNF-
, IL-6, IL-1ra, and TGF-
1 and
that 6 wk of fish oil supplementation did not affect exercise-induced cytokine levels, despite n-3 PUFA being incorporated into BMNC plasma membranes.
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge the excellent technical assistance of Ruth Rousing and Hanne Willumsen.
| |
FOOTNOTES |
|---|
This project was supported by The Danish National Research Foundation Grant 504-14.
Address for reprint requests and other correspondence: B. K. Pedersen, The Dept. of Infectious Diseases M7641, Rigshospitalet, Blegdamsvej 9,2100, Copenhagen 0, Denmark (E-mail: bkp{at}rh.dk).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 18 October 1999; accepted in final form 1 August 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aguilaniu, B,
Flore P,
Page E,
Maitre J,
Lacour JR,
and
Perrault H.
Effects of indomethacin and polyunsaturated fatty acid diet on exercise-induced hypoxaemia in master athletes.
Eur J Appl Physiol
77:
81-88,
1998.
2.
Aguilaniu, B,
Flore P,
Perrault H,
Page JE,
Payan E,
and
Lacour JR.
Exercise-induced hypoxaemia in master athletes: effects of a polyunsaturated fatty acid diet.
Eur J Appl Physiol
72:
44-50,
1995.
3.
Billiar, TR,
Bankey PE,
Svingen BA,
Curran RD,
West MA,
Holman RT,
Simmons RL,
and
Cerra FB.
Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation.
Surgery
104:
343-349,
1988[ISI][Medline].
4.
Bogdan, C,
and
Nathan C.
Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.
Ann NY Acad Sci
685:
713-739,
1993[Abstract].
5.
Bruunsgaard, H,
Galbo H,
Halkjaer-Kristensen J,
Johansen TL,
MacLean DA,
and
Pedersen BK.
Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage.
J Physiol (Lond)
499:
833-841,
1997[ISI].
6.
Bruunsgaard, H,
Skinh Qvist J,
and
Pedersen BK.
Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections.
J Infect Dis
180:
551-554,
1999[ISI][Medline].
7.
Calder, PC.
n-3 polyunsaturated fatty acids and cytokine production in health and disease.
Ann Nutr Metab
41:
203-234,
1997[ISI][Medline].
8.
Castell, LM,
Poortmans JR,
Leclercq R,
Brasseur M,
Duchateau J,
and
Newsholme EA.
Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation.
Eur J Appl Physiol
75:
47-53,
1997[ISI].
9.
Chen, LY,
Lawson DL,
and
Mehta JL.
Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor.
Thromb Res
76:
317-322,
1994[ISI][Medline].
10.
Dill, DB,
and
Costill DL.
Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.
J Appl Physiol
37:
247-248,
1974
11.
Drenth, JP,
Van Uum SH,
Van Deuren M,
Pesman GJ,
d. van V,
and
van der Meer JW.
Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-
and IL-1
production.
J Appl Physiol
79:
1497-1503,
1995
12.
Endres, S,
Ghorbani R,
Kelley VE,
Georgilis K,
Lonnemann G,
van der Meer JW,
Cannon JG,
Rogers TS,
Klempner MS,
and
Weber PC.
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.
N Engl J Med
320:
265-271,
1989[Abstract].
13.
Espersen, GT,
Elbaek A,
Ernst E,
Toft E,
Kaalund S,
Jersild C,
and
Grunnet N.
Effect of physical exercise on cytokines and lymphocyte subpopulations in human peripheral blood.
APMIS
98:
395-400,
1990[ISI][Medline].
14.
Ferrante, A,
Goh D,
Harvey DP,
Robinson BS,
Hii CS,
Bates EJ,
Hardy SJ,
Johnson DW,
and
Poulos A.
Neutrophil migration inhibitory properties of polyunsaturated fatty acids. The role of fatty acid structure, metabolism, and possible second messenger systems.
J Clin Invest
93:
1063-1070,
1994.
15.
Fletcher, MP,
and
Ziboh VA.
Effects of dietary supplementation with eicosapentaenoic acid or gamma-linolenic acid on neutrophil phospholipid fatty acid composition and activation responses.
Inflammation
14:
585-597,
1990[ISI][Medline].
16.
Fritsche, KL,
Alexander DW,
Cassity NA,
and
Huang SC.
Maternally-supplied fish oil alters piglet immune cell fatty acid profile and eicosanoid production.
Lipids
28:
677-682,
1993[ISI][Medline].
17.
Guarini, P,
Bellavite P,
Biasi D,
Carletto A,
Galvani S,
Caramaschi P,
Bambara LM,
and
Corrocher R.
Effects of dietary fish oil and soy phosphatidylcholine on neutrophil fatty acid composition, superoxide release, and adhesion.
Inflammation
22:
381-391,
1998[ISI][Medline].
18.
Hamon, G,
Mulloy RH,
Chen G,
Chow R,
Birkenmaier C,
and
Horn JK.
Transforming growth factor-beta 1 lowers the CD14 content of monocytes.
J Surg Res
57:
574-578,
1994[ISI][Medline].
19.
Hardardottir, I,
and
Kinsella JE.
Increasing the dietary (n-3) to (n-6) polyunsaturated fatty acid ratio increases tumor necrosis factor production by murine resident peritoneal macrophages without an effect on elicited peritoneal macrophages.
J Nutr
122:
1942-1951,
1992.
20.
Jolly, CA,
Jiang YH,
Chapkin RS,
and
McMurray DN.
Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide.
J Nutr
127:
37-43,
1997
21.
Kiefer, R,
Streit WJ,
Toyka KV,
Kreutzberg GW,
and
Hartung HP.
Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system.
Int J Dev Neurosci
13:
331-339,
1995[ISI][Medline].
22.
Kvasnicka, J,
and
Peskova M.
Prevention of thromboembolic complications in surgery.
Cas Lek Cesk
131:
165-169,
1992[Medline].
23.
Marie, C,
Cavaillon JM,
and
Losser MR.
Elevated levels of circulating transforming growth factor-beta 1 in patients with the sepsis syndrome.
Ann Intern Med
125:
520-521,
1996
24.
Miller-Graziano, CL,
Szabo G,
Kodys K,
and
Griffey K.
Aberrations in post-trauma monocyte (MO) subpopulation: role in septic shock syndrome.
J Trauma
30:
S86-S96,
1990[ISI][Medline].
25.
Moore, GE,
Holbein ME,
and
Knochel JP.
Exercise-associated collapse in cyclists is unrelated to endotoxemia.
Med Sci Sports Exerc
27:
1238-1242,
1995[ISI][Medline].
26.
Northoff, H,
and
Berg A.
Immunologic mediators as parameters of the reaction to strenuous exercise.
Int J Sports Med
12 Suppl 1:
S9-15,
1991.
27.
Oostenbrug, GS,
Mensink RP,
Hardeman MR,
De Vries T,
Brouns F,
and
Hornstra G.
Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E.
J Appl Physiol
83:
746-752,
1997
28.
Ostrowski, K,
Hermann C,
Bangash A,
Schjerling P,
Nielsen JN,
and
Pedersen BK.
A trauma-like elevation of plasma cytokines in humans in response to treadmill running.
J Physiol (Lond)
513:
889-894,
1998
29.
Ostrowski, K,
Rohde T,
Asp S,
Schjerling P,
and
Pedersen BK.
Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans.
J Physiol (Lond)
515:
287-291,
1999
30.
Ostrowski, K,
Rohde T,
Zacho M,
Asp S,
and
Pedersen BK.
Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running.
J Physiol (Lond)
508:
949-953,
1998
31.
Pedersen, BK,
Ostrowski K,
Rohde T,
and
Bruunsgaard H.
The cytokine response to strenuous exercise.
Can J Physiol Pharmacol
76:
505-511,
1998[ISI][Medline].
32.
Raastad, T,
Hostmark AT,
and
Stromme SB.
Omega-3 fatty acid supplementation does not improve maximal aerobic power, anaerobic threshold and running performance in well-trained soccer players.
Scand J Med Sci Sports
7:
25-31,
1997[ISI][Medline].
33.
Rohde, T,
MacLean DA,
Richter EA,
Kiens B,
and
Pedersen BK.
Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6.
Am J Physiol Endocrinol Metab
273:
E85-E91,
1997
34.
Sandström, B,
Aro A,
Becker W,
Lyhne N,
Pedersen JI,
and
Porsdottir I.
Nordiske näringsrekommendationer 1996.
Nord
28:
66-78,
1996.
35.
Schmidt, EB,
Varming K,
Pedersen JO,
Lervang HH,
Grunnet N,
Jersild C,
and
Dyerberg J.
Long-term supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte chemotaxis.
Scand J Clin Lab Invest
52:
229-236,
1992[ISI][Medline].
36.
Sprenger, H,
Jacobs C,
Nain M,
Gressner AM,
Prinz H,
Wesemann W,
and
Gemsa D.
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running.
Clin Immunol Immunopathol
63:
188-195,
1992[ISI][Medline].
37.
Tappia, PS,
and
Grimble RF.
Complex modulation of cytokine induction by endotoxin and tumour necrosis factor from peritoneal macrophages of rats by diets containing fats of different saturated, monounsaturated and polyunsaturated fatty acid composition.
Clin Sci (Colch)
87:
173-178,
1994[Medline].
38.
Tredget, EE,
Shankowsky HA,
Pannu R,
Nedelec B,
Iwashina T,
Ghahary A,
Taerum TV,
and
Scott PG.
Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b.
Plast Reconstr Surg
102:
1317-1328,
1998[ISI][Medline].
39.
Turner, M,
Chantry D,
Katsikis P,
Berger A,
Brennan FM,
and
Feldmann M.
Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.
Eur J Immunol
21:
1635-1639,
1991[ISI][Medline].
40.
Ullum, H,
Haahr PM,
Diamant M,
Palmo J,
Halkjaer-Kristensen J,
and
Pedersen BK.
Bicycle exercise enhances plasma IL-6 but does not change IL-1
, IL-1
, IL-6, or TNF-
pre-mRNA in BMNC.
J Appl Physiol
77:
93-97,
1994
41.
Varming, K,
Schmidt EB,
Svaneborg N,
Moller JM,
Lervang HH,
Grunnet N,
Jersild C,
and
Dyerberg J.
The effect of n-3 fatty acids on neutrophil chemiluminescence.
Scand J Clin Lab Invest
55:
47-52,
1995[ISI][Medline].
This article has been cited by other articles:
![]() |
A. M. W. Petersen and B. K. Pedersen The anti-inflammatory effect of exercise J Appl Physiol, April 1, 2005; 98(4): 1154 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Steensberg, C. Keller, R. L. Starkie, T. Osada, M. A. Febbraio, and B. K. Pedersen IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1272 - E1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Toft, L. B. Jensen, H. Bruunsgaard, T. Ibfelt, J. Halkjar-Kristensen, M. Febbraio, and B. K. Pedersen Cytokine response to eccentric exercise in young and elderly humans Am J Physiol Cell Physiol, July 1, 2002; 283(1): C289 - C295. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krzywkowski, E. W. Petersen, K. Ostrowski, J. H. Kristensen, J. Boza, and B. K. Pedersen Effect of glutamine supplementation on exercise-induced changes in lymphocyte function Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1259 - C1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krzywkowski, E. W. Petersen, K. Ostrowski, H. Link-Amster, J. Boza, J. Halkjaer-Kristensen, and B. K. Pedersen Effect of glutamine and protein supplementation on exercise-induced decreases in salivary IgA J Appl Physiol, August 1, 2001; 91(2): 832 - 838. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |